Mapping and stimulating brain–stomach connections in chronic nausea
Official title: TMS Neuromodulation of Brain-to-Stomach Circuits in Chronic Nausea
Run by University of Pittsburgh · NCT07276035 · Data updated 2026-11-12
This will test whether non-invasive brain stimulation (TMS) can change stomach activity and reduce nausea in adults with chronic nausea and in healthy volunteers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 60 Years |
| Sex | All |
| Enrollment | 219 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | January 28, 2026 |
| Main results expected | July 2030 |
| Study ends | July 2031 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT07276035 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 21–60 with self-reported chronic nausea and vomiting syndrome or healthy volunteers who meet safety criteria (no implants, no seizure history, BMI ≤30, not pregnant) are ideal candidates.
✕Probably not a fit
Patients outside the age or BMI range, those with prior gastric surgery, gastric cancer, neurodegenerative disease, a history of seizures, implantable devices, or on excluded medications (e.g., GLP-1 agonists or drugs that lower seizure threshold) are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study uses transcranial magnetic stimulation (TMS) while recording stomach electrical activity with surface electrodes (electrogastrogram, EGG) to identify brain sites that influence the stomach. Researchers will map gastric motor-evoked potentials (GMEPs), apply repetitive TMS to identified hotspots, and measure stomach responses during a satiety task (water load or nutrient drink/meal). Participants include adults with chronic nausea and healthy controls who will attend up to ten in-person visits over several months. Clinical, demographic, and autonomic data (for example EKG) will be collected as covariates to interpret differences between groups.
Why it matters
Potential benefit: If successful, this could lead to a non-invasive way to reduce nausea by targeting brain–stomach pathways.
How similar studies have gone: Related work is relatively novel: small prior studies suggest cortical stimulation can alter gastric rhythms, but clinical benefit for chronic nausea has not been established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults between ages 21-60 years old, with and without CNVS diagnosis per self-report. Exclusion Criteria: * body mass index (BMI) \> 30 * pregnancy or intention to become pregnant * past or present chemotherapy * diagnosis of gastric (stomach) cancer * any kind of gastric (stomach) surgery * current use of GLP-1 receptor agonists (e.g. Ozempic, Trulicity) * medications which significantly lower seizure thresholds (e.g. bupropion (Wellbutrin), fluoxetine (Prozac), or tramadol (Ultram)) * implantable devices, such as a pacemakers or nerve stimulators * history of head injury that required hospitalization, metal in the skull, or neurologic disease such as stroke, history of seizures or history of syncope (fainting or passing out) * neurodegenerative disease (Multiple Sclerosis, Parkinson's or Alzheimer's Disease) * ongoing psychosis or altered cognitive status status (e.g. hearing sounds or seeing visions that are not there, or feeling confused or suffering from memory lapses) * history of cardiovascular (i.e., heart attack), pulmonary (i.e., need for supplemental oxygen), or endocrine disease (e.g. diabetes) * current enrollment in another study using Transcranial Magnetic Stimulation (TMS) * current use of drugs such as amphetamines, methamphetamine, Ecstasy, Ketamine, Angel Dust/PCP, cocaine, or drinking 3 or more alcoholic drinks per day * For healthy subjects only: chronic history of gastrointestinal symptoms (e.g., nausea, indigestion, bloating, abdominal pain) * For CNVS subjects only: diagnosis of gastric motility disorder (e.g. gastroparesis/slow stomach emptying) or history of bowel obstruction (i.e., chronic partial small bowel obstruction)
Where it's running
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: David J Levinthal, MD PhD — University of Pittsburgh
- Study coordinator: Elijah D Wright
- Email: edw87@pitt.edu
- Phone: 412-647-1228
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can a wearable TENS device reduce chronic nausea symptoms?
This study tests whether the EmeTerm wearable TENS device can lessen nausea in adults with long-standing symptoms who are treated at Ohio State University.
-
Imaging Mitochondrial Complex-I and Brain Metabolism in Alcohol Use Disorder
This study tests whether PET imaging with [18F]BCPP-EF and [18F]FDG can reveal differences in brain energy use between adults with alcohol use disorder and healthy controls, and whether these measures relate to relapse risk.
-
Imaging Brain Mitochondrial Complex-I in Cocaine Use Disorder
This study uses a PET scan with [F-18]BCPP-EF to see how mitochondrial Complex-I activity in the brain differs between people with cocaine use disorder and healthy controls.
-
Managing nighttime voiding in older women with sleep strategies
This study tests whether brief behavioral sleep therapy and mindfulness, alone or together, reduce how often older women wake at night to urinate and how much urine they produce at night.
-
Personalized pain relief for knee OA using central nervous system-based duloxetine
This study tests whether duloxetine can improve walking and daily activity in people with knee osteoarthritis by comparing it to a placebo.
-
Which antibiotic works best for kids with sinus infections?
This study tests whether amoxicillin, amoxicillin-clavulanate, or a placebo help children with acute sinusitis feel better faster.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.